
Marg Helgenberger
Ask VT AI
View News Summary
- Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Thailand and Cambodia sign ceasefire at ASEAN summit, brokered by U.S. President Trump, but analysts warn of political and technical hurdles.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Ask VT AI
View News Summary
- Russia tests nuclear-powered cruise missile, raising concerns over technical challenges and strategic implications.
- Novartis nears $12B acquisition of Avidity Biosciences, a biotech with a promising platform for delivering RNA therapeutics to muscle tissue.
- Thailand and Cambodia sign ceasefire at ASEAN summit, brokered by U.S. President Trump, but analysts warn of political and technical hurdles.
20 hours

United States Politics
Discover the latest news, candidates, and key topics of US politics
Most Reported By
News from Marg Helgenberger
News from Marg Helgenberger
